Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults.
Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults.
复制标题
DOI:
10.1111/jgs.16558
复制
发表时间:
2020-09
影响因子:
6.3
通讯作者:
Muntner P
中科院分区:
文献类型:
--
作者:
Bowling CB;Sloane R;Pieper C;Luciano A;Davis BR;Simpson LM;Einhorn PT;Oparil S;Muntner P
Due to the high costs and excess mortality associated with multimorbidity, there is a need to develop approaches for delaying its progression. High blood pressure (BP) is a common chronic condition and a risk factor for many additional chronic conditions making it an ideal target for intervention. The purpose of this analysis was to determine the association between the level of sustained BP control and the progression of multimorbidity. Retrospective cohort study. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) linked to Medicare claims. 6,591 ALLHAT participants with Medicare who had systolic BP (SBP) measurements at ≥ 8 study visits. SBP control was categorized as <140 mm Hg at <50%, 50% to <75%, 75% to <100%, and 100% of visits. Multimorbidity progression was defined by the number of incident chronic conditions including arthritis, asthma, atrial fibrillation, cancer, chronic kidney disease, chronic obstructive pulmonary disease, coronary heart disease, dementia, depression, diabetes mellitus, heart failure, hyperlipidemia, osteoporosis, and stroke. Recurrent events survival analysis was used to calculate rate ratios (RRs) for the association of sustained SBP control with progression of multimorbidity. Rates of incident conditions per 10 person-years (95% CI) were 5.2 (5.1, 5.4), 4.7 (4.5, 4.8), 4.4 (4.2, 4.5), and 4.0 (3.8, 4.2) for participants with SBP control at <50%, 50% to <75%, 75% to <100%, and 100% of visits, respectively, over a median follow-up of 9.0 years. Compared to participants with SBP control at <50% of visits, adjusted RRs (95% CI) for multimorbidity progression were 0.90 (0.86, 0.95), 0.85 (0.81, 0.89), and 0.77 (0.72, 0.82) for those with SBP control at 50% to <75%, 75% to <100%, and 100% of visits, respectively. Sustaining BP control may be an effective approach to slow multimorbidity progression and reduce the population burden of multimorbidity.
登录
查看更多内容
影响因子:
37.8
作者:
Muntner P;Carey RM;Gidding S;Jones DW;Taler SJ;Wright JT Jr;Whelton PK
通讯作者:
Whelton PK
影响因子:
2.8
作者:
Bowling, C. Barrett;Davis, Barry R.;Muntner, Paul
通讯作者:
Muntner, Paul
影响因子:
11.1
作者:
Marengoni, A.;von Strauss, E.;Fratiglioni, L.
通讯作者:
Fratiglioni, L.
影响因子:
120.7
作者:
Boyd, CM;Darer, J;Wu, AW
通讯作者:
Wu, AW
影响因子:
1.9
作者:
Ghosh, D;Lin, DY
通讯作者:
Lin, DY